Drug intelligence / Profile preview

PUREACE-TC

Development stage
Unknown
Lead developer
Varmed Pharma
Modality
Recombinant Proteins and Enzymes, Small Molecules
Administration
Oral
01

Overview

PUREACE-TC is a fixed-dose combination analgesic and anti-inflammatory medication developed by Varmed Pharma. It contains aceclofenac, paracetamol, and the proteolytic enzymes trypsin and chymotrypsin. Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis by targeting cyclooxygenase (COX) enzymes. Paracetamol acts primarily through central analgesic pathways to provide pain relief and antipyretic effects. Trypsin and chymotrypsin are proteolytic enzymes that facilitate the resolution of inflammation and edema by breaking down fibrin clots and necrotic tissue. This combination is indicated for the management of pain and inflammation associated with musculoskeletal disorders, post-operative recovery, and sports injuries.

Brand names
PUREACE-TCPureace TC
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CTRC (Chymotrypsin C)PRSS1 (Trypsin family)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on PUREACE-TC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PUREACE-TC.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call